Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Methylation damage response in hematopoietic progenitor cells.

Casorelli I, Pelosi E, Biffoni M, Cerio AM, Peschle C, Testa U, Bignami M.

DNA Repair (Amst). 2007 Aug 1;6(8):1170-8. Epub 2007 May 15.

PMID:
17507295
2.

Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair.

Roos WP, Christmann M, Fraser ST, Kaina B.

Cell Death Differ. 2007 Aug;14(8):1422-32. Epub 2007 Apr 27.

3.

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

Kaina B, Christmann M, Naumann S, Roos WP.

DNA Repair (Amst). 2007 Aug 1;6(8):1079-99. Epub 2007 May 7. Review.

PMID:
17485253
4.

Stringent regulation of DNA repair during human hematopoietic differentiation: a gene expression and functional analysis.

Bracker TU, Giebel B, Spanholtz J, Sorg UR, Klein-Hitpass L, Moritz T, Thomale J.

Stem Cells. 2006 Mar;24(3):722-30. Epub 2005 Sep 29.

5.

[In vitro study on transduction of human O(6)-methylguanine-DNA-methyltransferase cDNA into human umbilical cord blood CD34(+) cells].

Wang J, Xia X, Chen Z, Lu D, Xue J, Ruan C.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2000 Dec;17(6):395-8. Chinese.

PMID:
11110975
7.

Change in expression of MGMT during maturation of human monocytes into dendritic cells.

Briegert M, Enk AH, Kaina B.

DNA Repair (Amst). 2007 Sep 1;6(9):1255-63. Epub 2007 Mar 26.

PMID:
17382605
8.
9.

[Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].

Tronov VA, Kramarenko II, Smirnova TD, Terekhov SM.

Tsitologiia. 2006;48(1):19-27. Russian.

PMID:
16568831
10.

Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Hofmann WK, Takeuchi S, Takeuchi N, Thiel E, Hoelzer D, Koeffler HP.

Leuk Res. 2006 Nov;30(11):1347-53. Epub 2006 May 8.

PMID:
16682076
11.

Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide.

Tao W, Hangoc G, Hawes JW, Si Y, Cooper S, Broxmeyer HE.

Exp Hematol. 2003 Mar;31(3):251-60.

PMID:
12644023
12.

[The maintenance of cord blood CD34+ progenitor cells with plant lectin FRIL in vitro and the expression of related cell cycle modulator HTm4 and HTm4S].

Xie XY, Xie C, Shi W, Li J, Li YH, Wang DM, Bai CX, Chen L, Pei XT.

Sheng Li Xue Bao. 2004 Jun 25;56(3):306-12. Chinese.

13.

Investigation of cell death induced by N-methyl-N-nitrosourea in cell lines of human origin and implication of RNA binding protein alterations.

Koryllou A, Patrinou-Georgoula M, Dimozi A, Kyrtopoulos SA, Pletsa V.

Anticancer Res. 2011 Dec;31(12):4291-9.

PMID:
22199294
15.
16.

Studies on BrdU labeling of hematopoietic cells: stem cells and cell lines.

Pang L, Reddy PV, McAuliffe CI, Colvin G, Quesenberry PJ.

J Cell Physiol. 2003 Nov;197(2):251-60.

PMID:
14502565
17.

5-Azacytidine supports the long-term repopulating activity of cord blood CD34(+) cells.

Suzuki M, Harashima A, Okochi A, Yamamoto M, Nakamura S, Motoda R, Yamasaki F, Orita K.

Am J Hematol. 2004 Nov;77(3):313-5.

19.
20.

BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.

Yamane K, Schupp JE, Kinsella TJ.

Cancer Res. 2007 Jul 1;67(13):6286-92.

Supplemental Content

Support Center